Mitogenic Cytokines Promote Apoptosis

Possible Roles in Cellular Homeostasis
  • Yufang Shi
  • Gordon B. Mills
  • Ruoxiang Wang

Abstract

Successful cell proliferation relies on the activation of genes involved in cell cycle progression and concurrent inhibition of the function of tumor suppressor genes. In addition, there is a need to maintain the viability in proliferating cells. In the absence of cell viability factors cell cycle progression is intrinsically linked to programmed cell death through apoptosis. Whereas much attention has been focused on the molecular description of cell cycle machinery and the apoptotic pathway, less attention has been paid to the mechanisms for maintenance of the cell viability while cells are progressing through the cell cycle. The interaction of mitogenic cytokines with their cognate receptors promotes entry to the S-phase of cell cycle. It has also been suggested that cytokines could directly provide cell survival signals based on the observations that cytokine withdrawal leads to apoptosis. However, it is not clear whether the mitogenic activities and the survival effects of these cytokines are exerted by a single biochemical mechanism or carried out through separate signaling pathways. It is, thus, important to establish whether the survival effects of cytokines are achieved directly or by synergizing with the action of survival factors present in the environment such as interstitial fluid or blood in vivo or culture medium in vitro. We have addressed this question by stimulating cells with cytokines in the presence or absence of exogenous serum in vitro. When incubated with cytokines in serum-free medium, several cell types underwent apoptosis, a phenomenon called cytokine-promoted apoptosis. Interestingly, we found that serum is the principle activator of the cell survival gene, Bcl-2; while mitogenic cytokines increase the expression of Bax. In this review, we discuss the relevance of cytokine-promoted apoptosis to the maintenance of cellular homeostasis during development and tumorigenesis.

Apoptosis, the main mechanism of programmed cell death, is a gene-directed process responsible for the elimination of excessive cells during development and detrimental cell types in pathophysiological situations (Wyllie et al., 1980). Aberrant apoptosis has been implicated in the etiology of cancer and the process of autoimmunity (Hale et al., 1996). It is also involved in the progression of some degenerative diseases as well as the evolution of drug resistance in tumors (Hickman, 1992). Deregulated expression of genes such as Bcl-2, loss of p53 expression, and autocrine activation of either apoptotic or antiapoptotic signal transduction pathways may all contribute to pathological apoptosis (McConkey et al., 1996).

Cell proliferation requires the modulation of at least two sets of genes: those that activate mitosis and those that maintain cell survival. The modulation of these genes is required to terminate cell cycle brakes, to activate cell cycle machinery, and to promote cell survival (Meikrantz and Schlegel, 1995). Much is known about the mechanisms of cell cycle promotion, the signals that regulate cell viability during cell cycle are yet to be determined.

Protooncogenes and tumor suppressor genes control and regulate cell cycle progression. In addition, both oncogenes and tumor suppressor genes play fundamental roles in the regulation of the pathways leading to programmed cell death (Chiarugi and Ruggiero, 1996). We have shown that the protooncogene c-Myc is required for activation-induced apoptosis in T cell hybridomas (Shi et al., 1992). Ectopic expression of Myc enhances cell cycle progression and, at the same time, promotes apoptosis of the cycling cells (Evan et al., 1992; Askew et al., 1993). It has also been shown that cyclin A and the CDK kinase inhibitor, p27, play fundamental roles in anti-IgM-induced apoptosis in B-cell lymphomas (Ezhevsky et al., 1996). This strongly suggests that cell cycle progression and apoptosis are tightly correlated, a notion which could have important implications in the understanding of the basic mechanisms regulating apoptosis. In this review, we explore the relationship between apoptosis and cell cycle progression by focusing on the recent studies in cytokine-promoted apoptosis, which will be important for the elucidation of the mechanisms by which normal cells manage to proliferate, and transformed cells undergo aberrant growth during tumorigenesis.

Keywords

Cell Cycle Cell Cycle Progression Early Response Gene Cell Cycle Machinery Cell Survival Signal 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alitalo, K., and Schwab, M. (1986). Oncogene amplification in tumor cells. Adv Cancer Res 47, 235–281.PubMedCrossRefGoogle Scholar
  2. Askew, D.S., Ihle, J.N., and Cleveland, J.L. (1993). Activation of apoptosis associated with enforced Myc expression in myeloid progenitor cells is dominant to the suppression of apoptosis by interleukin-3 or erythropoietin. Blood 82, 2079–2087.PubMedGoogle Scholar
  3. Blandino, G., Scardigli, R., Rizzo, M.G., Crescenzi, M., Soddu, S., and Sacchi, A. (1995). Wild-type p53 modulates apoptosis of normal, IL-3 deprived, hematopoietic cells. Oncogene 10, 731–737.PubMedGoogle Scholar
  4. Borset, M., Medvedev, A.E., Sundan, A., and Espevik T. (1996). The role of the two TNF receptors in proliferation, NF-kappa B activation and discrimination between TNF and LT alpha signalling in the human myeloma cell line OH-2. Cytokine 8, 430–438.PubMedCrossRefGoogle Scholar
  5. Branch, D.R., and Guilbert, L.J. (1996). Autocrine regulation of macrophage proliferation by tumor necrosis factor-alpha. Exp. Hematol. 24, 675–681.PubMedGoogle Scholar
  6. Chiarugi, V., and Ruggiero, M. (1996). Role of three cancer “master genes” p53, Bell and c-Myc on the apoptotic process. Tumori. 82, 205–209.PubMedGoogle Scholar
  7. Choi, M.S., Boise, L.H., Gottschalk, A.R., Quintans, J., Thompson, C.B., and Klaus, GG. (1995). The role of Bel-XL in CD40-mediated rescue from anti-mu-induced apoptosis in WEHI-231 B lymphoma cells. Eur. J. Immunol. 25, 1352–1357.PubMedCrossRefGoogle Scholar
  8. Colombel, M., Olsson, C.A., Ng, P.Y., and Buttyan, R. (1992). Hormone-regulated apoptosis results from reentry of differentiated prostate cells onto a defective cell cycle. Cancer Res. 52, 4313–319.PubMedGoogle Scholar
  9. Dimri, G.P., Nakanishi, M., Desprez, P.Y., Smith, J.R., and Campisi, J. (1996). Inhibition of E2F activity by the cyclin-dependent protein kinase inhibitor p21 in cells expressing or lacking a functional retinoblastoma protein. Mol. Cell. Biol. 16, 2987–2997.PubMedGoogle Scholar
  10. Dubrez, L., Goldwasser, F., Genne, P., Pommier, Y., and Solary, E. (1995). The role of cell cycle regulation and apoptosis triggering in determining the sensitivity of leukemic cells to topoisomerase I and II inhibitors. Leukemia 9, 1013–1024.PubMedGoogle Scholar
  11. Evan, G.I., Wyllie, A.H., Gilbert, C.S., Littlewood, T.D., Land, H., Brooks, M., Waters, C.M., Penn, L.Z., and Hancock, D.C. (1992). Induction of apoptosis in fibroblasts by c-Myc protein. Cell 69, 119–128.PubMedCrossRefGoogle Scholar
  12. Ewen, M.E. (1994). The cell cycle and the retinoblastoma protein family. Cancer Metastasis Rev. 13, 45–66.PubMedCrossRefGoogle Scholar
  13. Ezhevsky, S.A., Toyoshima, H., Hunter, T., and Scott, D.W. (1996). Role of cyclin A and p27 in anti-IgM induced Gl growth arrest of murine B-cell lymphomas. Mol. Biol. Cell 7, 553–564.PubMedGoogle Scholar
  14. Galaktionov, K., Chen, X., and Beach, D. (1996). Cdc25 cell-cycle phosphatase as a target of c-Myc. Nature 382, 511–517.PubMedCrossRefGoogle Scholar
  15. Garte, S.J. (1993). The c-Myc oncogene in tumor progression. Crit Rev Oncogene 4, 435–449.Google Scholar
  16. Gartel, A.L., Serfas, M.S., and Tyner, A.L. (1996). p21-negative regulator of the cell cycle. Proc. Soc. Exp. Biol. Med. 213, 138–149.PubMedGoogle Scholar
  17. Hale, A.J., Smith, C.A., Sutherland, L.C., Stoneman, V.E., Longthorne, V.L., Culhane, A.C., and Williams, G.T. (1996). Apoptosis: molecular regulation of cell death. Eur. J. Biochem. 236, 1–26.PubMedCrossRefGoogle Scholar
  18. Harrington, E.A., Bennett, M.R., Fanidi. A., and Evan, GI. (1994). c-Myc-vinduced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J 13, 3286–3295.PubMedGoogle Scholar
  19. Harris, R.A., Hiles, I.D., Page, M.J., and O’Hare, M.J. (1995). The induction of apoptosis in human mammary luminal epithelial cells by expression of activated c-neu and its abrogation by glucocorticoids. Br. J. Cancer 72, 386–392.PubMedCrossRefGoogle Scholar
  20. Hickman, JA. (1992). Apoptosis induced by anticancer drugs. Cancer Metastasis Rev 11, 121–139.PubMedCrossRefGoogle Scholar
  21. Hiebert, S.W., Packham, G., Strom, D.K., Haffner, R., Oren, M., Zambetti, G., and Cleveland, J.L. (1995). E2F-1:DP-1 induces p53 and overrides survival factors to trigger apoptosis. Mol. Cell. Biol. 15, 6864–6874.PubMedGoogle Scholar
  22. Higuchi, M., Singh, S., and Aggarwal, B.B. (1995). Characterization of the apoptotic effects of human tumor necrosis factor: development of highly rapid and specific bioassay for human tumor necrosis factor and lym-photoxin using human target cells. J. Immunol. Methods 178, 173–181.PubMedCrossRefGoogle Scholar
  23. Hinds, P.W., and Weinberg, RA. (1994). Tumor suppressor genes. Curr. Opin. Genet. Dev. 4, 135–141.PubMedCrossRefGoogle Scholar
  24. Hurlin, P.J., Ayer, D.E., Grandori, C., and Eisenman, R.N. (1994). The Max transcription factor network: involvement of Mad in differentiation and an approach to identification of target genes. Cold Spring Harb. Symp. Quant. Biol. 59, 109–116.PubMedCrossRefGoogle Scholar
  25. Janicke, R.U., Lee, F.H., and Porter, A.G. (1994). Nuclear c-Myc plays an important role in the cytotoxicity of tumor necrosis factor alpha in tumor cells. Mol. Cell. Biol. 14, 5661–5670.PubMedCrossRefGoogle Scholar
  26. Johnson, D.G., Schwarz, J.K., Cress, W.D., and Nevins, J.R. (1993). Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 365, 349–352.PubMedCrossRefGoogle Scholar
  27. Klefstrom, J., Vastrik, I., Saksela, E., Valle, J., Eilers, M., and Alitalo, K. (1994). c-Myc induces cellular susceptibility to the cytotoxic action of TNF-alpha. EMBO J. 13, 5442–5450.PubMedGoogle Scholar
  28. Kondo S. (1995). Apoptosis by antitumor agents and other factors in relation to cell cycle checkpoints. J. Radiat. Res. (Tokyo) 36, 56–62.CrossRefGoogle Scholar
  29. Larsson, L.G., Pettersson, M., Oberg, F., Nilsson, K., and Luscher, B. (1994). Expression of mad, mxil, max and c-Myc during induced differentiation of hematopoietic cells: opposite regulation of mad and c-Myc. Oncogene 9, 1247–1252.PubMedGoogle Scholar
  30. Lee, W.M. (1989). The Myc family of nuclear proto-oncogenes. Cancer Treat Res 47, 37–71.PubMedCrossRefGoogle Scholar
  31. Lenardo, M.J. (1991). Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. Nature 353, 858–861.PubMedCrossRefGoogle Scholar
  32. Liebermann, D.A., Hoffman, B., and Steinman, R.A. (1995). Molecular controls of growth arrest and apoptosis: p53-dependent and independent pathways. Oncogene 11, 199–210.PubMedGoogle Scholar
  33. MacLachlan, T.K., Sang, N., and Giordano, A. (1995). Cyclins, cyclin-dependent kinases and cdk inhibitors: implications in cell cycle control and cancer. Crit. Rev. Eukaryot. Gene Expr. 5, 127–156.PubMedCrossRefGoogle Scholar
  34. Martin, K., Trouche, D., Hagemeier, C., and Kouzarides, T. (1995). Regulation of transcription by E2F1/DP1. J. Cell. Sci. Suppl. 19, 91–94.PubMedCrossRefGoogle Scholar
  35. McConkey, D.J., Zhivotovsky, B., and Orrenius, S. (1996). Apoptosis-molecular mechanisms and biomedical implications. Mol. Aspects Med. 17, 1–110.PubMedCrossRefGoogle Scholar
  36. Meikrantz, W, and Schlegel, R. (1995). Apoptosis and the cell cycle. J. Cell. Biochem. 58, 160–174.PubMedCrossRefGoogle Scholar
  37. Miyashita, T., Harigai, M., Hanada, M., and Reed, J.C. (1994). Identification of a p53-dependent negative response element in the Bcl-2 gene. Cancer Res. 54, 3131–3135.PubMedGoogle Scholar
  38. Miyashita, T., and Reed, J.C. (1995). Tumor suppressor p53 is a direct transcriptional activator of the human Bax gene. Cell 80, 293–299.PubMedCrossRefGoogle Scholar
  39. Montenarh, M. (1992). Biochemical, immunological, and functional aspects of the growth-suppressor/oncoprotein p53. Crit. Rev. Oncog. 3, 233–256.PubMedGoogle Scholar
  40. Murray, M.J., Cunningham, J.M., Parada, L.F., Dautry, F., Lebowitz, P., and Weinberg, R.A. (1983). The HL-60 transforming sequence: a ras oncogene coexisting with altered Myc genes in hematopoietic tumors. Cell 33, 749–757.PubMedCrossRefGoogle Scholar
  41. Nevins, J.R. (1992). E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 258, 424–429.PubMedCrossRefGoogle Scholar
  42. Pandey, S., and Wang, E. (1995). Cells en route to apoptosis are characterized by the upregulation of c-fos, c-Myc, c-jun, cdc2, and RB phosphorylation, resembling events of early cell-cycle traverse. J. Cell. Biochem. 58, 135–150.PubMedCrossRefGoogle Scholar
  43. Pica, F., Franzese, O., D’Onofrio, C., Bonmassar, E., Favalli, C., and Garaci E. (1996). Prostaglandin E2 induces apoptosis in resting immature and mature human lymphocytes: a c-Myc-dependent and Bcl-2-independent associated pathway. J. Pharmacol. Exp. Ther. 277, 1793–1800.PubMedGoogle Scholar
  44. Radvanyi, L.G., Shi, Y.F., Mills, G.B., and Miller, R. (1996). Cell cycle progression out of Gl sensitizes primarycultured nontransformed T cells to TCR-mediated apoptosis. Cell. Immunol. 170:260–273.PubMedCrossRefGoogle Scholar
  45. Rabizadeh, S., Oh, J., Zhong, L.T., Yang, J., Bitler, C.M., Butcher, L.L., and Bredesen, D.E. (1993). Induction of apoptosis by the low-affinity NGF receptor. Science 261, 345–348.PubMedCrossRefGoogle Scholar
  46. Russell, J.H., White, C.L., Loh, D.L., and Meleedy-Rey, P. (1991). Receptor-stimulated death pathway is opened by antigen in mature T cells. Proc. Natl. Acad. Sci, U.S.A., 88, 2151–2155.PubMedCrossRefGoogle Scholar
  47. Shan, B., and Lee, W.H. (1994). Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol. Cell. Biol. 14, 8166–8173.PubMedGoogle Scholar
  48. Shi, Y.S, Bissonnette, R.P, Glynn, J.M, Cotter, T.G., Guilbert, J.L., and Green, D.R. (1992). Inhibition of activation-induced apoptosis in T cell hybridomas by antisense oligodeoxynucleotides corresponding to c-Myc. Science 257, 212–214.PubMedCrossRefGoogle Scholar
  49. Shi, Y.S., Radvanyi, L.G., Mills, G.B., and Miller, R.G. (1995). CD28 ligation inhibits TCR-induced apoptosis during a primary T cell response and prevents induction of T cell hyporesponsiveness. J. Immunol. 156, 1788–1798.Google Scholar
  50. Spencer, C.A., and Groudine, M. (1991). Control of c-Myc regulation in normal and neoplastic cells. Adv. Cancer Res. 56, 1–48.PubMedCrossRefGoogle Scholar
  51. Tiwari, R.K., Wong, G.Y., Liu, J., Miller, D., and Osborne, M.P. (1991). Augmentation of cytotoxicity using combinations of interferons (types I and II), tumor necrosis factor-alpha, and tamoxifen in MCF-7 cells. Cancer Lett. 61, 45–52.PubMedCrossRefGoogle Scholar
  52. Ucker, D.S. (1991). Death by suicide: one way to go in mammalian cellular development? New Biol. 3, 103–109.PubMedGoogle Scholar
  53. Vairapandi, M., Balliet, A.G., Fornace, A.J. Jr, Hoffman, B., and Liebermann, D.A. (1996). The differentiation primary response gene MyD118, related to GADD45, encodes for a nuclear protein which interacts with PCNA and p21 WAF1/CIP1. Oncogene 12, 2579–2594.PubMedGoogle Scholar
  54. Wong, G.H. Protective roles of cytokines against radiation: induction of mitochondrial MnSOD. Biochim. Biophys. Acta. 1271, 205-209.Google Scholar
  55. Wu, S., Pena, A., Korcz, A., Soprano, D.R., and Soprano, K.J. (1996). Overexpression of Mxil inhibits the induction of the human ornithine decarboxylase gene by the Myc/Max protein complex. Oncogene 12, 621–629.PubMedGoogle Scholar
  56. Wyllie, A.H., Kerr, J.F.R., and Currie, A.R. (1980). Cell death: The significance of apoptosis. Int. Rev. Cytol. 68, 251–306.PubMedCrossRefGoogle Scholar
  57. Zola H. (1996). Analysis of receptors for cytokines and growth factors in human disease. Dis. Markers 12, 225–240.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1997

Authors and Affiliations

  • Yufang Shi
    • 1
  • Gordon B. Mills
    • 2
  • Ruoxiang Wang
    • 1
  1. 1.Department of Immunology, Holland LaboratoryAmerican Red CrossRockvilleUSA
  2. 2.Department of Molecular OncologyMD Anderson Cancer Center University of TexasHoustonUSA

Personalised recommendations